ABION Inc. (KOSDAQ:203400)
3,570.00
-155.00 (-4.16%)
At close: Feb 20, 2026
ABION Market Cap
ABION has a market cap or net worth of 321.66 billion as of February 20, 2026. Its market cap has increased by 60.46% in one year.
Market Cap
321.66B
Enterprise Value
341.25B
Revenue
1.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,570.00
Market Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 321.66B, an increase of 486.09%. That is a compound annual growth rate of 22.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 335.63B | 19.01% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ToolGen | 489.83B |
| S.Biomedics | 470.63B |
| Y-Biologics | 397.67B |
| GC Cell | 369.67B |
| NIBEC | 360.30B |
| curacle co.,ltd. | 295.56B |
| Genome & Company | 273.91B |
| ISU Abxis | 226.00B |